https://biotechmorning.com/news/life-biosciences-80m-epigenetic-reprogramming-glaucoma Biotech Morning en 2026-04-09T14:14:04.790Z The $80M Bet That You Can Turn Back Time Inside Your Eyes https://biotechmorning.com/news/vivtex-novo-nordisk-2-billion-deal Biotech Morning en 2026-04-09T14:13:19.743Z The MIT Spinout That Just Landed a $2.1B Bet From Novo Nordisk https://biotechmorning.com/news/roche-biggest-gpu-pharma-supercomputer Biotech Morning en 2026-04-09T14:12:33.725Z Roche Just Built Pharma's Biggest Supercomputer. Here's Why. https://biotechmorning.com/news/avalyn-pharma-ipo-inhaled-lung-therapies Biotech Morning en 2026-04-09T14:11:55.595Z Avalyn Pharma Wants to Breathe New Life Into the IPO Market https://biotechmorning.com/news/akari-wuxi-adc-deal-geopolitical-risk Biotech Morning en 2026-04-09T14:11:09.439Z The Biotech That Walked Right Into a Geopolitical Minefield https://biotechmorning.com/news/shionogi-barda-us-antibiotic-manufacturing Biotech Morning en 2026-04-09T14:10:23.397Z Why the U.S. Government Is Paying a Japanese Company to Make Antibiotics in America https://biotechmorning.com/news/roche-c4t-protein-degradation-deal Biotech Morning en 2026-04-09T14:09:34.083Z Roche Just Took a $1 Billion 'Leap of Faith' on a Cancer-Killing Trick https://biotechmorning.com/news/gilead-45m-kymera-protein-degrader-deal Biotech Morning en 2026-04-09T14:08:50.072Z Gilead's $45M Bet on a Drug That Destroys Cancer Proteins https://biotechmorning.com/news/novo-wegovy-price-war-obesity Biotech Morning en 2026-04-09T14:08:05.861Z Novo Just Started a Price War That Could Change How America Loses Weight https://biotechmorning.com/news/anthropic-claude-banned-federal-healthcare Biotech Morning en 2026-04-08T14:10:16.812Z The Safest AI in Tech Just Got Banned From U.S. Healthcare https://biotechmorning.com/news/biogen-alloy-anticlastic-aso-partnership Biotech Morning en 2026-04-08T14:09:39.953Z Biogen's Bet on a Twisted Piece of Chemistry https://biotechmorning.com/news/sidewinder-therapeutics-137m-series-b-adc Biotech Morning en 2026-04-08T14:08:55.017Z $137 Million for a Cancer Drug That Doesn't Exist Yet https://biotechmorning.com/news/jeito-capital-1-2-billion-european-biopharma-fund Biotech Morning en 2026-04-08T14:08:08.348Z Europe's Biggest Bet on Itself Just Got a $1.2 Billion Price Tag https://biotechmorning.com/news/triglyceride-aneurysm-causal-link-first-drug-lead Biotech Morning en 2026-04-08T14:07:25.809Z The Condition With Zero Drugs Just Found Its First Lead